We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
Cap. Flow
+$423M
Cap. Flow %
5.97%
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358

Top Buys

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$188M
2
LH icon
Labcorp
LH
+$183M
3
AGN
Allergan Inc
AGN
+$144M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$93.8M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$82.2M

Top Sells

Rank Stock Value
1
BKD icon
Brookdale Senior Living
BKD
+$104M
2
CAH icon
Cardinal Health
CAH
+$104M
3
AGN
Allergan plc
AGN
+$80.7M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$60.3M
5
ELV icon
Elevance Health
ELV
+$55.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.3%
2 Consumer Discretionary 5.38%
3 Financials 4.49%
4 Industrials 3.37%
5 Technology 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEA icon
76
Lear
LEA
$7.39B
$17.1M 0.24%
174,259
-22,141
-11% -$2.03M
RVNC
77
DELISTED
Revance Therapeutics, Inc.
RVNC
$16.9M 0.24%
+1,000,000
New +$17.5M
VOD icon
78
CALL
Vodafone
VOD
$37.1B
$16.4M 0.23%
480,100
+475,390
+10,093% +$16M
STLD icon
79
Steel Dynamics
STLD
$36.4B
$16.4M 0.23%
828,872
+317,629
+62% +$6.85M
COR icon
80
CALL
Cencora
COR
$62B
$16.3M 0.23%
+180,500
New +$15.5M
CODE
81
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
$16.1M 0.23%
471,593
+52,813
+13% +$1.25M
ENZY
82
DELISTED
Enzymotec Ltd
ENZY
$16M 0.23%
2,125,000
– –
ZTS icon
83
Zoetis
ZTS
$32.7B
$15.5M 0.22%
+360,048
New +$14.6M
HCBK
84
DELISTED
HUDSON CITY BANCORP INC
HCBK
$15.5M 0.22%
1,528,938
+858,906
+128% +$8.29M
KATE
85
DELISTED
Kate Spade & Company
KATE
$15.5M 0.22%
+482,627
New +$13.8M
CVD
86
DELISTED
COVANCE INC.
CVD
$15.1M 0.21%
+145,835
New +$13.7M
GOOG icon
87
Alphabet (Google) Class C
GOOG
$4.11T
$15M 0.21%
569,098
-291,639
-34% -$7.83M
AGTC
88
DELISTED
Applied Genetic Technologies Corporation
AGTC
$14.6M 0.21%
692,625
– –
PFE icon
89
Pfizer
PFE
$143B
$14.4M 0.2%
488,065
+282,961
+138% +$8.11M
WPM icon
90
Wheaton Precious Metals
WPM
$49.7B
$14.4M 0.2%
+707,376
New +$14.1M
GNMK
91
DELISTED
GenMark Diagnostics, Inc
GNMK
$14.4M 0.2%
1,055,373
+217,927
+26% +$2.44M
VXX
92
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$14.3M 0.2%
28,281
+27,811
+5,917% +$13.7M
TEVA icon
93
Teva Pharmaceuticals
TEVA
$40.4B
$14.1M 0.2%
+245,064
New +$13.7M
ALLY icon
94
PUT
Ally Financial
ALLY
$13.1B
$13.9M 0.2%
590,000
+587,400
+22,592% +$13.3M
UNM icon
95
Unum
UNM
$13.4B
$13.8M 0.19%
395,037
+381,487
+2,815% +$12.9M
SPY icon
96
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$13.5M 0.19%
+65,785
New +$13.2M
PCRX icon
97
Pacira BioSciences
PCRX
$1.04B
$13.3M 0.19%
+150,072
New +$14.2M
URI icon
98
United Rentals
URI
$65.7B
$13.2M 0.19%
129,656
+68,274
+111% +$7.32M
HIG icon
99
Hartford Financial Services
HIG
$39.9B
$13.2M 0.19%
316,390
-364,962
-54% -$14.4M
PRU icon
100
Prudential Financial
PRU
$42.6B
$13.2M 0.19%
145,617
+8,896
+7% +$764K
2 3
4
5 6

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.

  • Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
  • Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
  • Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
  • Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
  • Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
  • Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
  • Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.

Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.